Valbiotis SA (EPA:ALVAL)
France · Delayed Price · Currency is EUR 0.5530
0.00 (0.00%)
Oct 23, 2026, 9:31 AM CEST
Valbiotis Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1.34 | 0.91 | 0.18 | 4.73 | 0.79 | 0.3 |
Other Revenue | -0 | - | 0 | - | - | - |
| 1.34 | 0.91 | 0.18 | 4.73 | 0.79 | 0.3 | |
Revenue Growth | 182.07% | 414.21% | -96.28% | 502.93% | 163.42% | -90.36% |
Cost of Revenue | 2.04 | 2.07 | 2.34 | 2.04 | - | - |
Gross Profit | -0.7 | -1.17 | -2.16 | 2.69 | 0.79 | 0.3 |
Selling, General & Admin | 8.22 | 7.24 | 7.46 | 4.18 | 3.35 | 2.62 |
Research & Development | 0.64 | 0.92 | 4.64 | 7.15 | 9.1 | 7.03 |
Other Operating Expenses | -1.62 | -0.14 | -4.47 | -2.08 | -2.03 | -2.4 |
Operating Expenses | 7.29 | 8.33 | 8.26 | 9.85 | 12.77 | 8.7 |
Operating Income | -7.99 | -9.49 | -10.43 | -7.16 | -11.99 | -8.41 |
Interest Expense | -0.16 | -0.16 | -0.23 | -0.19 | -0.23 | -0.23 |
Interest & Investment Income | 0.19 | 0.21 | - | - | - | - |
Other Non Operating Income (Expenses) | -0.05 | 0.02 | 0.66 | - | -0.06 | 0.02 |
EBT Excluding Unusual Items | -8.19 | -9.42 | -9.99 | -7.35 | -12.27 | -8.61 |
Other Unusual Items | - | - | 0 | -0.02 | -0.04 | -0.07 |
Pretax Income | -8.19 | -9.42 | -9.99 | -7.37 | -12.31 | -8.68 |
Income Tax Expense | - | 0 | 0.03 | - | -0 | - |
Net Income | -8.19 | -9.42 | -10.03 | -7.37 | -12.31 | -8.68 |
Net Income to Common | -8.19 | -9.42 | -10.03 | -7.37 | -12.31 | -8.68 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | - | 20 | 16 | 12 | 10 | 9 |
Shares Outstanding (Diluted) | - | 20 | 16 | 12 | 10 | 9 |
Shares Change | - | 25.53% | 26.74% | 23.21% | 10.45% | 22.88% |
EPS (Basic) | - | -0.47 | -0.63 | -0.59 | -1.22 | -0.95 |
EPS (Diluted) | - | -0.47 | -0.63 | -0.59 | -1.22 | -0.95 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -8.88 | -8.05 | -11.68 | -8.08 | -9.3 | -7.46 |
Free Cash Flow Per Share | - | -0.41 | -0.74 | -0.65 | -0.92 | -0.81 |
Gross Margin | -52.65% | -128.84% | - | 56.81% | 100.00% | 100.00% |
Operating Margin | -597.53% | -1049.06% | -5923.86% | -151.28% | -1526.88% | -2820.80% |
Profit Margin | -612.72% | -1040.55% | -5696.02% | -155.67% | -1568.41% | -2913.09% |
Free Cash Flow Margin | -663.87% | -889.06% | -6638.64% | -170.78% | -1185.10% | -2504.03% |
EBITDA | -7.84 | -9.2 | -9.84 | -6.42 | -11.13 | -7.47 |
EBITDA Margin | - | - | - | -135.73% | - | - |
D&A For EBITDA | 0.15 | 0.3 | 0.59 | 0.74 | 0.85 | 0.94 |
EBIT | -7.99 | -9.49 | -10.43 | -7.16 | -11.99 | -8.41 |
EBIT Margin | - | - | - | -151.28% | - | - |
Revenue as Reported | 2.96 | 1.05 | 4.64 | 6.81 | 2.81 | 2.69 |